Drug Shortage Report for MYOCHRYSINE

Last updated on 2019-06-10 History
Report ID 29274
Drug Identification Number 01927604
Brand name MYOCHRYSINE
Common or Proper name Myochrisine 50mg/1ml
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GOLD SODIUM THIOMALATE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5
ATC code M01CB
ATC description SPECIFIC ANTIRHEUMATIC AGENTS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2017-11-24
Actual start date 2017-12-01
Estimated end date 2019-09-30
Actual end date 2019-06-04
Shortage status Resolved
Updated date 2019-06-10
Company comments The continued global shortage of Myochrysine is due to manufacturing issues with the active ingredient. Consequently Sanofi has decided to discontinue all three strengths of Myochrysine globally.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2018-06-12 French Compare
v22 2018-09-07 English Compare
v23 2018-09-07 French Compare
v24 2019-06-10 English Compare
v25 2019-06-10 English Compare
v26 2019-06-10 French Compare

Showing 21 to 26 of 26